Fredrik Erixon

Fredrik Erixon is a Swedish economist and writer. He has been the Director of the European Centre for International Political Economy (ECIPE) ever since its start in 2006. The Financial Times has ranked Erixon as one of Brussels 30 most influential people.

Fredrik Erixon is the author of several books and studies in the fields of international economics, economic policy, and regulatory affairs (welfare reforms, healthcare, competition policy, et cetera). His latest book (co-authored with Björn Weigel) was The Innovation Illusion: How so Little is Created by so Many Working so Hard (Yale University Press) and he has previously written books about the history of political ideas, the role of social capital for economic growth, and international economic policy. His research interests covers international economics, European relations with Asia and North America, trade and regulatory policy, philosophy and technological change. His next book, Saving Liberalism for the 21st Century, is about challenges from populism and other ideas to the open society.

Erixon has advised several governments in Europe and the rest of the world and is a frequent speaker at conferences. He regularly writes for international newspapers and magazines. In his previous career, Erixon has worked in development policy, financial markets, business consulting, and academia.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More